Hydrafacial Results Presentation Deck

1 2 3 4 5 SIGNIFICANT NET SALES GROWTH DEMONSTRATES STRENGTH OF BRAND $260.1 mm exceeded 2021 guidance with a +118.3% increase vs FY20 and +56.2% increase vs FY19 I KEY HIGHLIGHTS 4Q21 GROSS MARGIN / ADJUSTED GROSS MARGIN¹ EXPANSION OF +1,210 BPS / +870 BPS VS 4Q20 72.9% GAAP / 76.5% adjusted as cost leverage increasing with growth and distributor acquisition accretion offset supply chain environment CONTINUED EXECUTION OF EXISTING STRATEGY Master Plan remains in place, focus on flawless execution and expanding talent GROWTH OPPORTUNITY REMAINS SIGNIFICANT 2022 outlook of double-digit sales growth via innovation and geographic expansion I VISIBILITY INTO ACCELERATED PATHWAY TO GREATER PROFITABILITY Final elevated investment year of 2022 paves way for adjusted EBITDA margin¹ expansion in 2023 Non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure 5

View entire presentation